Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.
Advanced Medical Solutions Group Stock Performance
Shares of LON:AMS traded down GBX 3.50 ($0.04) during midday trading on Monday, hitting GBX 295.50 ($3.62). 46,763 shares of the stock traded hands, compared to its average volume of 291,739. The firm has a 50-day moving average of GBX 290.09 and a two-hundred day moving average of GBX 288.85. The firm has a market capitalization of £640.13 million and a P/E ratio of 3,737.50. The company has a debt-to-equity ratio of 4.64, a quick ratio of 5.52 and a current ratio of 6.76. Advanced Medical Solutions Group has a one year low of GBX 253.50 ($3.11) and a one year high of GBX 347 ($4.25).
Insider Activity
In related news, insider A Christopher (Chris) Meredith sold 246,384 shares of the firm's stock in a transaction on Tuesday, May 10th. The stock was sold at an average price of GBX 271 ($3.32), for a total value of £667,700.64 ($818,160.32).